載入...
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivat...
Na minha lista:
| 發表在: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319972/ https://ncbi.nlm.nih.gov/pubmed/28275367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00031 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|